Table 2.
Patient characteristics
| Total (N = 1104) | Pre- CRRT intervention (N = 515) | Post- CRRT intervention (N = 589) | P | |
|---|---|---|---|---|
| Dermographic characteristics | ||||
| Age, year | 63.85 ± 14.39 | 63.05 ± 14.67 | 64.56 ± 14.13 | 0.083 |
| Male, % | 62.8 | 63.9 | 61.8 | 0.493 |
| Height, cm | 163.59 ± 8.53 | 163.63 ± 8.10 | 163.56 ± 8.91 | 0.884 |
| Weight.kg | 61.85 ± 12.07 | 61.65 ± 12.23 | 62.03 ± 11.65 | 0.602 |
| BMI.kg/m2 | 23.07 ± 3.97 | 22.94 ± 3.82 | 23.18 ± 4.09 | 0.320 |
| Surgical ICU, % | 19.3 | 17.5 | 20.9 | 0.169 |
| Medical ICU, % | 80.7 | 82.5 | 79.1 | 0.169 |
| Disease status | ||||
| MAP, mmHg | 79.45 ± 17.73 | 78.01 ± 18.49 | 80.72 ± 16.95 | 0.012 |
| SOFA score | 10.59 ± 3.98 | 11.03 ± 4.04 | 10.21 ± 3.90 | 0.001 |
| Vasopressor use, % | 63.5 | 70.5 | 57.4 | <0.001 |
| Ventilator use, % | 61.3 | 68.0 | 55.5 | <0.001 |
| Laboratory findings | ||||
| WBC, 10E3/uL | 14.35 ± 10.82 | 13.78 ± 9.90 | 14.84 ± 11.55 | 0.103 |
| Hb, g/dL | 10.35 ± 2.40 | 10.34 ± 2.41 | 10.36 ± 2.39 | 0.884 |
| Hct, % | 30.71 ± 7.54 | 30.93 ± 8.02 | 30.52 ± 7.09 | 0.373 |
| Platete, 10E3/uL | 143.52 ± 102.86 | 131.03 ± 93.10 | 154.4 ± 109.60 | <0.001 |
| Total protein, g/dL | 5.47 ± 1.09 | 5.36 ± 1.11 | 5.56 ± 1.08 | 0.004 |
| Albumin, g/dL | 2.95 ± 0.69 | 2.89 ± 0.69 | 3.02 ± 0.67 | 0.001 |
| BUN, mg/dL | 53.91 ± 31.46 | 55.55 ± 33.51 | 52.48 ± 29.51 | 0.106 |
| Cr, mg/dL | 3.59 ± 2.79 | 3.57 ± 2.86 | 3.61 ± 2.73 | 0.816 |
| Na, mmol/L | 138.06 ± 8.91 | 138.16 ± 10.25 | 137.97 ± 7.56 | 0.727 |
| K, mmol/L | 4.51 ± 1.10 | 4.53 ± 1.12 | 4.50 ± 1.08 | 0.696 |
| TCO2, mmol/L | 16.74 ± 6.13 | 15.84 ± 5.92 | 17.52 ± 6.21 | <0.001 |
| PT, INR | 1.65 ± 0.97 | 1.66 ± 1.05 | 1.64 ± 0.88 | 0.688 |
CRRT continuous renal replacement therapy; BMI body mass index; ICU intensive care unit; MAP mean arterial pressure; SOFA sequential organ failure assessment; Hb hemoglobin; BUN blood urea nitrogen; Cr creatinine; tCO2 total carbon dioxide; PT prothrombin time